A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis

  • Hodge, Alex, (Primary Chief Investigator (PCI))

Project: Research

Project Description

NMA HREC Reference Number: MDF/54879/DEF-2019-176067(v1)
NMA SSA Reference Number: SSA/54879/MonH-2019-183612(v2)
Monash Health Ref Number: RES-19-0000-603X
StatusActive
Effective start/end date4/09/193/09/24

Keywords

  • phase 3 study
  • treatment efficacy
  • Sclerosing Cholangitis
  • clinical trial